BIOMAT Database Logo BIOMAT Database Logo

An inactivated gE-negative marker vaccine and an experimental gD-subunit vaccine reduce the incidence of bovine herpesvirus 1 infections in the field. 1998

J C Bosch, and M C De Jong, and P Franken, and K Frankena, and J J Hage, and M J Kaashoek, and M A Maris-Veldhuis, and J P Noordhuizen, and W H Van der Poel, and J Verhoeff, and K Weerdmeester, and G M Zimmer, and J T Van Oirschot
Holland Genetics, Arnhem, The Netherlands.

An inactivated glycoprotein E-negative vaccine and an experimental glycoprotein D-subunit vaccine against bovine herpesvirus 1 (V1) were examined for their effectiveness in a randomized, double-bline, placebo-controlled field trial comprising 130 dairy farms. The use of these marker vaccines enabled us to monitor the incidence of infections in vaccinated populations. The aims of this trial were to evaluate whether these vaccines: (1) reduce the proportion of outbreaks in dairy herds; and (2) reduced virus transmission within dairy herds and to what extent. Vaccination with either of the two vaccines significantly reduced the proportion of herds wherein an outbreak occurred as well as the virus transmission within herds, as compared to placebo-treated herds. The estimated number of secondary cases caused by one infectious animal, expressed as the reproduction ratio R, was for both vaccines significantly > 1. This indicates that when BHV1 is introduced into vaccinated herds, major outbreaks may still occur.

UI MeSH Term Description Entries
D007242 Herpesvirus 1, Bovine A species of VARICELLOVIRUS that causes INFECTIOUS BOVINE RHINOTRACHEITIS and other associated syndromes in CATTLE. IBR-IPV Virus,Infectious Bovine Rhinotracheitis Virus,Infectious Pustular Vulvovaginitis Virus,Bovine Herpesvirus 1,Bovine Rhinotracheitis Virus, Infectious,Herpesvirus 1 (alpha), Bovine,Pustular Vulvovaginitis Virus, Infectious,IBR IPV Virus,IBR-IPV Viruses,Virus, IBR-IPV,Viruses, IBR-IPV
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D002418 Cattle Diseases Diseases of domestic cattle of the genus Bos. It includes diseases of cows, yaks, and zebus. Bovine Diseases,Bovine Disease,Cattle Disease,Disease, Bovine,Disease, Cattle,Diseases, Bovine,Diseases, Cattle
D005260 Female Females
D006566 Herpesviridae Infections Virus diseases caused by the HERPESVIRIDAE. Herpesvirus Infections,B Virus Infection,Infections, Herpesviridae,Infections, Herpesvirus,B Virus Infections,Herpesviridae Infection,Herpesvirus Infection,Infection, B Virus,Infection, Herpesviridae,Infection, Herpesvirus,Infections, B Virus
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D014759 Viral Envelope Proteins Integral membrane proteins that are incorporated into the VIRAL ENVELOPE. They are glycosylated during VIRAL ASSEMBLY. Envelope Proteins, Viral,Viral Envelope Glycoproteins,Viral Envelope Protein,Virus Envelope Protein,Virus Peplomer Proteins,Bovine Leukemia Virus Glycoprotein gp51,Hepatitis Virus (MHV) Glycoprotein E2,LaCrosse Virus Envelope Glycoprotein G1,Simian Sarcoma Virus Glycoprotein 70,Viral Envelope Glycoprotein gPr90 (Murine Leukemia Virus),Viral Envelope Glycoprotein gp55 (Friend Virus),Viral Envelope Proteins E1,Viral Envelope Proteins E2,Viral Envelope Proteins gp52,Viral Envelope Proteins gp70,Virus Envelope Proteins,Envelope Glycoproteins, Viral,Envelope Protein, Viral,Envelope Protein, Virus,Envelope Proteins, Virus,Glycoproteins, Viral Envelope,Peplomer Proteins, Virus,Protein, Viral Envelope,Protein, Virus Envelope,Proteins, Viral Envelope,Proteins, Virus Envelope,Proteins, Virus Peplomer
D014764 Viral Proteins Proteins found in any species of virus. Gene Products, Viral,Viral Gene Products,Viral Gene Proteins,Viral Protein,Protein, Viral,Proteins, Viral

Related Publications

J C Bosch, and M C De Jong, and P Franken, and K Frankena, and J J Hage, and M J Kaashoek, and M A Maris-Veldhuis, and J P Noordhuizen, and W H Van der Poel, and J Verhoeff, and K Weerdmeester, and G M Zimmer, and J T Van Oirschot
Early immunity induced by a live gE-negative bovine herpesvirus 1 marker vaccine.
November 1996, Veterinary microbiology,
J C Bosch, and M C De Jong, and P Franken, and K Frankena, and J J Hage, and M J Kaashoek, and M A Maris-Veldhuis, and J P Noordhuizen, and W H Van der Poel, and J Verhoeff, and K Weerdmeester, and G M Zimmer, and J T Van Oirschot
An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines.
October 1996, Veterinary microbiology,
J C Bosch, and M C De Jong, and P Franken, and K Frankena, and J J Hage, and M J Kaashoek, and M A Maris-Veldhuis, and J P Noordhuizen, and W H Van der Poel, and J Verhoeff, and K Weerdmeester, and G M Zimmer, and J T Van Oirschot
Effect of vaccination against bovine herpesvirus 1 with inactivated gE-negative marker vaccines on the health of dairy cattle herds.
March 2015, Preventive veterinary medicine,
J C Bosch, and M C De Jong, and P Franken, and K Frankena, and J J Hage, and M J Kaashoek, and M A Maris-Veldhuis, and J P Noordhuizen, and W H Van der Poel, and J Verhoeff, and K Weerdmeester, and G M Zimmer, and J T Van Oirschot
A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs.
November 1996, Veterinary microbiology,
J C Bosch, and M C De Jong, and P Franken, and K Frankena, and J J Hage, and M J Kaashoek, and M A Maris-Veldhuis, and J P Noordhuizen, and W H Van der Poel, and J Verhoeff, and K Weerdmeester, and G M Zimmer, and J T Van Oirschot
Enhancement of the immune response and virological protection of calves against bovine herpesvirus type 1 with an inactivated gE-deleted vaccine.
May 2003, The Veterinary record,
J C Bosch, and M C De Jong, and P Franken, and K Frankena, and J J Hage, and M J Kaashoek, and M A Maris-Veldhuis, and J P Noordhuizen, and W H Van der Poel, and J Verhoeff, and K Weerdmeester, and G M Zimmer, and J T Van Oirschot
A gE-negative bovine herpesvirus 1 vaccine strain is not re-excreted nor transmitted in an experimental cattle population after corticosteroid treatments.
April 2000, Vaccine,
J C Bosch, and M C De Jong, and P Franken, and K Frankena, and J J Hage, and M J Kaashoek, and M A Maris-Veldhuis, and J P Noordhuizen, and W H Van der Poel, and J Verhoeff, and K Weerdmeester, and G M Zimmer, and J T Van Oirschot
Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
April 2006, Vaccine,
J C Bosch, and M C De Jong, and P Franken, and K Frankena, and J J Hage, and M J Kaashoek, and M A Maris-Veldhuis, and J P Noordhuizen, and W H Van der Poel, and J Verhoeff, and K Weerdmeester, and G M Zimmer, and J T Van Oirschot
A specific PCR to differentiate between gE negative vaccine and wildtype bovine herpesvirus type 1 strains.
April 1999, Veterinary microbiology,
J C Bosch, and M C De Jong, and P Franken, and K Frankena, and J J Hage, and M J Kaashoek, and M A Maris-Veldhuis, and J P Noordhuizen, and W H Van der Poel, and J Verhoeff, and K Weerdmeester, and G M Zimmer, and J T Van Oirschot
Inactivated bovine herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine.
October 1997, Vaccine,
J C Bosch, and M C De Jong, and P Franken, and K Frankena, and J J Hage, and M J Kaashoek, and M A Maris-Veldhuis, and J P Noordhuizen, and W H Van der Poel, and J Verhoeff, and K Weerdmeester, and G M Zimmer, and J T Van Oirschot
Efficacy of a live glycoprotein E-negative bovine herpesvirus 1 vaccine in cattle in the field.
February 2001, Vaccine,
Copied contents to your clipboard!